Brief: Gufic Biosciences Says USFDA Pre-Approval Inspection At Indore Facility
Yesterday 16:13
BRIEF-Gufic Biosciences Says USFDA Pre-Approval Inspection At Indore Facility Oct 23 (Reuters) - Gufic Biosciences Ltd GUFI.NS:
GUFIC BIOSCIENCES - USFDA PRE-APPROVAL INSPECTION AT INDORE FACILITY
GUFIC BIOSCIENCES - RECEIVED 3 OBSERVATIONS IN FORM FDA 483
Source text: ID:nBSE5pBCFl
Further company coverage: GUFI.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Gufic Biosciences
See all newsBrief: Gufic Biosciences Says USFDA Pre-Approval Inspection At Indore Facility
Brief: Gufic Biosciences June-Quarter Consol Total Profit 223.1 Million Rupees
Brief: Gufic Biosciences Receives Tax Demand Notice For 43.3 Million Rupees
Brief: Gufic Biosciences Receives Tax Demand Notice For 43.3 Million Rupees
Brief: Gufic Biosciences posts Sept-Quarter Consol Revenue From Operations 2.37 Billion Rupees